Publications by authors named "Vanita Chopra"

16Publications

Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's Disease.

PLoS One 2017 23;12(1):e0170275. Epub 2017 Jan 23.

Department of Neurology, MassGeneral Institute of Neurodegenerative Diseases, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, United States of America.

View Article and Find Full Text PDF
August 2017

LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington's Disease.

J Huntingtons Dis 2016 12;5(4):347-355

Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA, USA.

View Article and Find Full Text PDF
December 2016

Rho Kinase Pathway Alterations in the Brain and Leukocytes in Huntington's Disease.

Mol Neurobiol 2016 May 5;53(4):2132-40. Epub 2015 May 5.

Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Harvard Medical School, Massachusetts General Hospital, East, Bldg 114, Room 2005, Charlestown, MA, 02129-4404, USA.

View Article and Find Full Text PDF
May 2016

Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model.

Neurobiol Dis 2014 Nov 8;71:34-42. Epub 2014 Jul 8.

Department of Veterinary Sciences, University of Wyoming, Laramie, WY 82070, USA; Neuroscience Graduate Program, University of Wyoming, Laramie, WY 82070, USA. Electronic address:

View Article and Find Full Text PDF
November 2014

Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse.

Proc Natl Acad Sci U S A 2011 Oct 3;108(41):17141-6. Epub 2011 Oct 3.

Laboratory for Neurogenomics, Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Cambridge, MA 02139, USA.

View Article and Find Full Text PDF
October 2011

The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS.

Hum Mol Genet 2011 Oct 26;20(20):3986-96. Epub 2011 Jul 26.

MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Boston, MA 02115, USA.

View Article and Find Full Text PDF
October 2011

A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse.

Proc Natl Acad Sci U S A 2007 Oct 9;104(42):16685-9. Epub 2007 Oct 9.

Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA 02129, USA.

View Article and Find Full Text PDF
October 2007

Mechanisms of copper ion mediated Huntington's disease progression.

PLoS One 2007 Mar 28;2(3):e334. Epub 2007 Mar 28.

Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.

View Article and Find Full Text PDF
March 2007

Concurrent cisplatin and radiotherapy in advanced head and neck cancer.

Indian J Otolaryngol Head Neck Surg 2003 Apr;55(2):94-6

Deptt of Otorhmolaryngology, Aligarh, India.

View Article and Find Full Text PDF
April 2003